Ditch the spreadsheet look by using floating charts, custom slicers, and a full-screen interface to create professional-grade ...

Turn Excel into a lightweight data-science tool for cleaning datasets, standardizing dates, visualizing clusters, and analyzing keywords.

BILLERICA, Mass.--(BUSINESS WIRE)--Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), today announced a partnership with Life Line Screening (LLS), a national organization focused on ...

The combination of belzutifan (Welireg) and lenvatinib (Lenvima) led to superior outcomes, compared with cabozantinib (Cabometyx), in a phase 3 trial of patients with advanced clear cell renal cell ...

Japanese chipmaker Rapidus is advancing its 2nm process technology while developing advanced packaging solutions tailored for AI chips. The company aims to officially start trial production on its ...

In August, Zongertinib received FDA approval for previously treated HER2-mutant NSCLC. It now shows efficacy in first-line treatment, with a 77% objective response rate and 96% disease control rate.

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Oklo Inc. (OKLO), an advanced nuclear technology company, announced today that it has been selected by the U.S. Department of Energy (DOE), along with three ...

Similar to the DOE’s Reactor Pilot Program, in which Oklo was also selected to participate, the Fuel Line Pilot Projects are designed to accelerate the permitting, construction, and operation, drive ...

Three weeks into the high-school football season, a big and experienced offensive line has been clearing the way to help the Washington-Liberty Generals to a 3-0 start. The line has opened holes for ...

The National Institute for Health and Care Excellence (NICE) has recommended the combination of enfortumab vedotin (Padcev, Astellas) with pembrolizumab (Keytruda, MSD) as a first-line option for ...

This paid press release is provided by Tron and was not written by CoinDesk. CoinDesk does not endorse and is not responsible or liable for this content. SAN FRANCISCO, July 9, 2025 – The Graph, the ...